top of page

Aries Biotech Partners with NeuroTheranostics, Inc.

Peptide-based Strategies for Healing Neurological Damage

Aries Biotech and NeuroTheranostics are merging their collective expertise in research and development to address potential impact of synthetic, protease-targeting compounds upon the central nervous system. These strategies have the potential to mitigate a broad spectrum of injuries and diseases.

To learn how we can assist with your needs within science and medicine, visit Aries Biotech at

23 views0 comments

Recent Posts

See All

Are you interested in #biomarkers and #therapeutics for #neurologicaldisease and #brainhealth? Aries Biotech want to hear from you! Your perspective holds immense value for us and we recognize the vit

Aries Biotech extends gratitude to CSIRO, Australia's national science agency, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to discuss health initiatives. At Aries Biotech, we believ

Revolutionizing Neuroscience and Neurotrauma: Aries Biotech Announces New Services Available to KOLs and Investors Aries Biotechnologies is thrilled to introduce

bottom of page